Healthcare • Drug Manufacturers - Specialty & Generic
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if PAHC is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
24 top institutions tracked
Last 13F trend: distributing (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 2
209 filers reported a long position in PAHC for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| BlackRock, Inc. | $101.1M | 3.2M | -1.1% |
| FMR LLC | $99.2M | 3.2M | +45.4% |
| STATE STREET CORP | $32.6M | 1M | +9.3% |
| MILLENNIUM MANAGEMENT LLC | $29.4M | 936.7K | +1,578.1% |
| VANGUARD CAPITAL MANAGEMENT LLC | $29M | 923.3K | +3.6% |
| GEODE CAPITAL MANAGEMENT, LLC | $20.6M | 657.4K | +8.7% |
| LORD, ABBETT & CO. LLC | $20.5M | 653.3K | +64.3% |
| DIMENSIONAL FUND ADVISORS LP | $16.7M | 531.1K | +4.6% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $16M | 508.5K | +3.7% |
| RENAISSANCE TECHNOLOGIES LLC | $15.1M | 480.5K | -16.7% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.